Product Code: GVR-1-68038-456-7
Protein Engineering Market Growth & Trends:
The global protein engineering market size is expected to reach USD 7.62 billion by 2030, registering a CAGR of 16.24% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the key factors fueling the industry's growth is the rising demand for non-chemical medicinal alternatives for the treatment of chronic diseases globally. Furthermore, due to the favorable clinical outcomes connected to protein-based treatments, these therapeutics are now preferred over conventional synthesized pharmaceuticals, which is expected to accelerate market growth. The rising number of government activities, such as funding research and advancement for engineering novel therapeutics further influence the industry growth.
In addition, the market is positively impacted by improvements in healthcare infrastructure, an increase in healthcare spending, growth in the geriatric population, and an increase in investments in health-related research & development globally. Furthermore, key companies are expected to have profitable opportunities due to the growth in technological advancements in the protein engineering field. For instance, in February 2022, Tierra Biosciences unveiled the Tierra Protein Platform, an e-commerce platform that enables consumers to receive unique protein engineering products manufactured, verified, and dispatched to them in only a few clicks.
The platform offered by Tierra offers a quicker and more practical alternative to conventional approaches for finding thousands of proteins for use in R&D. The COVID-19 pandemic has boosted the industry growth due to applications of protein engineering in the production of COVID-19 vaccines and diagnostics. A bioluminescent diagnostic kit, for instance, was developed in July 2021 by scientists at the Eindhoven University of Technology in Germany. It can be utilized to determine whether an individual's immune system is producing antibodies in reaction to the coronavirus. Similarly, it is anticipated that the market will witness substantial growth during the forecast period as a result of the rising R&D efforts for engineering COVID-19 treatments.
Protein Engineering Market Report Highlights:
- The instruments product segment accounted for the highest market share in 2023. High demand for efficient and high throughput instruments for chromatographic analysis in protein engineering applications is driving the segment
- The rational protein design technology segment accounted for the largest share in 2023. Protein remodeling engineering is an emerging and important application of rational design and serves as a major factor contributing to the growth of the segment due to its highly reliable and rapid processing attributes
- The monoclonal antibodies protein type segment held the largest share in 2023. Monoclonal bodies find applications in the treatment of autoimmune disorders and with the rising prevalence of such diseases, the segment is anticipated to witness a rapid growth
- The pharmaceutical and biotechnology companies end-use segment held the largest share in 2023. Rising R&D expenditure by biotechnology and pharmaceutical firms and increasing government funding and support for engineering advanced therapies are boosting the segment growth
- North America accounted for the largest share in 2023 due to the rising use of biological medications for the treatment of chronic diseases, as well as rising funding opportunities in the region for R&D activities
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Product
- 1.2.2. Technology
- 1.2.3. Protein Type
- 1.2.4. End-use
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing adoption of protein-based drugs
- 3.2.1.2. Increasing research & development activities in the biopharmaceutical industry
- 3.2.1.3. Growing funding opportunities for protein engineering
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High maintenance costs associated with protein engineering tools & instruments
- 3.2.2.2. Limited availability of qualified researchers and need for advanced training in protein engineering
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. Protein Engineering Market: Product Business Analysis
- 4.1. Product Segment Dashboard
- 4.2. Global Protein Engineering Market Product Movement Analysis
- 4.3. Global Protein Engineering Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Instruments
- 4.4.1. Global Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Reagents
- 4.5.1. Global Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Software & Services
- 4.6.1. Global Software & Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Protein Engineering Market: Technology Business Analysis
- 5.1. Technology Segment Dashboard
- 5.2. Global Protein Engineering Market Technology, Movement Analysis
- 5.3. Global Protein Engineering Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
- 5.4. Rational Protein Design
- 5.4.1. Global Rational Protein Design Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Directed Evolution
- 5.5.1. Global Directed Evolution Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Hybrid Approach
- 5.6.1. Global Hybrid Approach Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. De Novo Protein Design
- 5.7.1. Global De Novo Protein Design Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8. Others
- 5.8.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Protein Engineering Market: Protein Type Business Analysis
- 6.1. Protein Type Segment Dashboard
- 6.2. Global Protein Engineering Market Protein Type Movement Analysis
- 6.3. Global Protein Engineering Market Size & Trend Analysis, by Protein Type, 2018 to 2030 (USD Million)
- 6.4. Insulin
- 6.4.1. Global Insluin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Monoclonal Antibodies
- 6.5.1. Global Monoclonal Antibodies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Vaccines
- 6.6.1. Global Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Growth Factors
- 6.7.1. Global Growth Factors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8. Colony Stimulating Factors
- 6.8.1. Global Colony Stimulating Factors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.9. Coagulation Factors
- 6.9.1. Global Coagulation Factors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.10. Interferons
- 6.10.1. Global Interferons Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.11. Others
- 6.11.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Protein Engineering Market: End-use Business Analysis
- 7.1. End-use Segment Dashboard
- 7.2. Global Protein Engineering Market End-use Movement Analysis
- 7.3. Global Protein Engineering Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
- 7.4. Academic Research Institutes
- 7.4.1. Global Academic Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Contract Research Organizations
- 7.5.1. Global Contract Research Organizations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Pharmaceutical & Biotechnology Companies
- 7.6.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Protein Engineering Market: Regional Estimates & Trend Analysis by Product, Technology, Protein Type, and End-use
- 8.1. Regional Dashboard
- 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 8.3. North America
- 8.3.1. North America Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.2. U.S.
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Scenario
- 8.3.2.3. Regulatory Framework
- 8.3.2.4. U.S. Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.3. Canada
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. Canada Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4. Europe
- 8.4.1. Europe Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.2. UK
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. UK Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Germany
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. Germany Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. France
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. France Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.5. Italy
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. Italy Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.6. Spain
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Spain Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.7. Denmark
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Scenario
- 8.4.7.3. Regulatory Framework
- 8.4.7.4. Denmark Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.8. Sweden
- 8.4.8.1. Key Country Dynamics
- 8.4.8.2. Competitive Scenario
- 8.4.8.3. Regulatory Framework
- 8.4.8.4. Sweden Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.9. Norway
- 8.4.9.1. Key Country Dynamics
- 8.4.9.2. Competitive Scenario
- 8.4.9.3. Regulatory Framework
- 8.4.9.4. Norway Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5. Asia Pacific
- 8.5.1. Asia Pacific Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. Japan
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Japan Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. China
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. China Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.4. India
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Competitive Scenario
- 8.5.4.3. Regulatory Framework
- 8.5.4.4. India Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.5. Australia
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Competitive Scenario
- 8.5.5.3. Regulatory Framework
- 8.5.5.4. Australia Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.6. Thailand
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Competitive Scenario
- 8.5.6.3. Regulatory Framework
- 8.5.6.4. Thailand Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.7. South Korea
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Competitive Scenario
- 8.5.7.3. Regulatory Framework
- 8.5.7.4. South Korea Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6. Latin America
- 8.6.1. Latin America Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. Brazil
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. Brazil Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. Mexico
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Mexico Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. Argentina
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competitive Scenario
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. Argentina Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7. MEA
- 8.7.1. MEA Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.2. South Africa
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Competitive Scenario
- 8.7.2.3. Regulatory Framework
- 8.7.2.4. South Africa Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.3. Saudi Arabia
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Competitive Scenario
- 8.7.3.3. Regulatory Framework
- 8.7.3.4. Saudi Arabia Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.4. UAE
- 8.7.4.1. Key Country Dynamics
- 8.7.4.2. Competitive Scenario
- 8.7.4.3. Regulatory Framework
- 8.7.4.4. UAE Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.5. Kuwait
- 8.7.5.1. Key Country Dynamics
- 8.7.5.2. Competitive Scenario
- 8.7.5.3. Regulatory Framework
- 8.7.5.4. Kuwait Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Participant Categorization
- 9.2. Strategy Mapping
- 9.3. Company Market Position Analysis, 2023
- 9.4. Participant's Overview
- 9.4.1. Agilent Technologies, Inc.
- 9.4.1.1. Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Strategic Initiatives
- 9.4.2. Thermo Fisher Scientific Inc.
- 9.4.2.1. Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Strategic Initiatives
- 9.4.3. Bruker Corporation
- 9.4.3.1. Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Strategic Initiatives
- 9.4.4. PerkinElmer, Inc.
- 9.4.4.1. Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Strategic Initiatives
- 9.4.5. Waters Corporation
- 9.4.5.1. Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Strategic Initiatives
- 9.4.6. Bio-Rad Laboratories
- 9.4.6.1. Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Strategic Initiatives
- 9.4.7. Merck KGaA
- 9.4.7.1. Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Strategic Initiatives
- 9.4.8. Danaher Corporation
- 9.4.8.1. Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Strategic Initiatives
- 9.4.9. Genscript Biotech Corp
- 9.4.9.1. Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Strategic Initiatives
- 9.4.10. Amgen Inc.
- 9.4.10.1. Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Product Benchmarking
- 9.4.10.4. Strategic Initiatives